系统性硬化症相关大便失禁:聚焦被忽视表现的范围综述
本范围综述基于Arksey与O'Malley方法框架,检索PubMed(Medline)与Web of Science,筛选454篇摘要后纳入61篇文章(含32篇原创研究),总结系统性硬化症患者大便失禁的流行病学、发病机制、临床表现与评估方法,并提出研究议程。
要点
- 原创研究中大便失禁患病率为0.4%至77%(限于未将大便失禁列为强制纳入标准者)。
- 血管病与细胞外基质沉积伴内括约肌纤维替代是核心致病事件,内括约肌受累重于外括约肌。
- 无验证性诊断方法,47%原创研究用肛门直肠测压评估直肠生理,保守治疗为综述与指南推荐的第一步。
核心结论
- 这是首个探讨系统性硬化症大便失禁的范围综述,作者提出新研究议程以改善治疗策略并促进对这一被忽视表现的研究。
研究设计与样本
- 范围综述,方法学框架基于Arksey与O'Malley提出的框架,检索PubMed(Medline)与Web of Science两个数据库,使用预设模板提取数据。
主要发现
- 共筛选454篇摘要,最终纳入61篇文章,其中32篇为原创研究。
- 在未将大便失禁列为强制纳入标准的原创研究中,大便失禁患病率为0.4%至77%。
- 内括约肌受累较外括约肌更重,小动脉血管病与细胞外基质沉积伴内括约肌纤维替代是关键致病事件。
- 原创研究中最常报告的患者报告结局为Wexner大便失禁评分(占原创研究的22%),其次为UCLA SCTC-GIT 2.0(占原创研究的16%)。
- 尽管系统性硬化症大便失禁无验证性诊断方法,47%的原创研究使用肛门直肠测压评估系统性硬化症患者的直肠生理。
关键数值与推荐
- 纳入的叙述性综述与指南提出,治疗稀便或硬便的保守措施(包括止泻药物与饮食调整)是大便失禁管理的第一步。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This scoping review sought to summarize the current knowledge on the epidemiology, pathogenesis and clinical presentation of, and the investigations that may help characterize faecal incontinence (FI) in patients with SSc. METHODS: The planned scoping review was based on the methodological framework proposed by Arksey and O'Malley. Two databases were screened: PubMed (Medline), (Web of Science), and data extraction was performed using a predefined template. RESULTS: A total of 454 abstracts were screened and 61 articles were finally included, comprising 32 original articles. The prevalence of FI was 0.4% to 77% in original articles that did not use FI among the mandatory inclusion criteria. Internal anal sphincter was reported as more impacted than external sphincter and vasculopathy of arterioles and extracellular matrix deposition with fibrous replacement of the internal sphincter were the key underlaying pathogenic events. The most represented patient-reported outcome in original articles was the Wexner FI score (22% of original articles) followed by the UCLA SCTC-GIT 2.0 (16% of original articles). Although there is no validated diagnostic approach for FI in SSc, 47% of original articles used anorectal manometry to assess rectal physiology in SSc patients. Conservative measures to treat either liquid or hard stool including anti-diarrhoeal medications and dietary adjustments were the first step of proposed FI management in included narrative reviews and guidelines. CONCLUSION: This is the first scoping review exploring FI in SSc. We propose a new research agenda which may help improve treatment strategies and foster research focusing on a neglected manifestation of SSc.
引用
- Lescoat A, Zimmermann F, Murray CD, et al. Systemic sclerosis-related fecal incontinence: a scoping review focusing on a neglected manifestation. Rheumatology (Oxford). 2025. PMID: 39693125. doi:10.1093/rheumatology/keae691
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。